Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Philippe Adamowicz"'
Autor:
Christian Bréchot, François-Noël Marie, Agnès Laplanche, Françoise Degos, Philippe Adamowicz, Jean-Pierre Benhamou, Marc Girard, Alain Goudeau, Pierre Saliou, Anne-Marie Couroucé, F. Tron
Publikováno v:
Journal of Infectious Diseases. 160:199-204
The safety and immunogenicity of different doses (2, 5, 10, and 20 micrograms of a recombinant hepatitis B virus (rHBV) vaccine containing the S and PreS2 sequences and produced in mammalian cells were compared to those of a plasma-derived hepatitis
Autor:
J.L. Barres, J. P. Chiron, Yves Buisson, B. Yvonnet, Pierre Saliou, Pierre Coursaget, Philippe Adamowicz, Ibrahima Diop Mar, C. Bourdil
Publikováno v:
Vaccine. 6:357-361
Anti-pre-S 2 antibodies were detected by enzyme-linked immuno-adsorbant assay using a synthetic peptide analogue of pre-S 2 protein, in different groups of hepatitis-B-infected subjects, including patients presenting with cirrhosis and liver cancer,
Autor:
M.N. Mevelec, Chiron Jp, Pierre Coursaget, Philippe Adamowicz, J.L. Barres, R. N'Doye, I. Diop Mar, B. Yvonnet, C. Bourdil, J. Chotard
Publikováno v:
Lancet (London, England). 2(8572)
A viral infection characterised by serum HBsAg positivity with serum anti-HBc negativity has been encountered in Senegal. The infection is not associated with the presence of HBeAg, so it differs from hepatitis B virus in its core antigen, but the su
Autor:
Pierre Reculard, Philippe Adamowicz, François Hyafil, Georges Lucas, Roger Vinas, Paul Prunet, Gisèle Chabanier
Publikováno v:
Vaccine. 2(3)
As first generation hepatitis B vaccines are derived from human plasma, detailed information is required concerning the elimination of hepatitis B virus and other potential transmissible infectious agents during vaccine preparation. To demonstrate th